Ignite Creation Date:
2024-05-06 @ 7:55 AM
Last Modification Date:
2024-10-26 @ 11:53 AM
Study NCT ID:
NCT02626507
Status:
UNKNOWN
Last Update Posted:
2022-02-09
First Post:
2015-12-07
Brief Title:
Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ERHER2- Breast Cancer
Sponsor:
Hoffman Oncology
Organization:
Hoffman Oncology
Organization Data
Organization:
Hoffman Oncology
Class:
OTHER
Study ID:
CL- Gedatolisib-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hoffman Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| DSCS CRO | INDUSTRY |